Open-label pilot study of memantine in the treatment of compulsive buying

Annals of Clinical Psychiatry

Volumn 24, Issue 2, 2012, Pages 119-126

  Grant, Jon E ^a   Odlaug, Brian L ^a   Mooney, Marc ^a   O'Brien, Robert ^a   Kim, Suck Won ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Buying; Cognition; Impulse control; Shopping

Indexed keywords

AMFEBUTAMONE; BUSPIRONE; CITALOPRAM; DULOXETINE; MEMANTINE; SERTRALINE;

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL ARTICLE; COGNITION; COMPULSION; COMPULSIVE BUYING; DECREASED APPETITE; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FINANCIAL MANAGEMENT; HUMAN; IMPULSIVENESS; MALE; PRIORITY JOURNAL; SIDE EFFECT; TINNITUS; TOBACCO DEPENDENCE; TREATMENT OUTCOME;

ADULT; COMPULSIVE BEHAVIOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MEMANTINE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, N-METHYL-D-ASPARTATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84865225624     PISSN: 10401237     EISSN: 15473325     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Christenson GA, Faber RJ, de Zwaan M, et al. Compulsive buying: descriptive characteristics and psychiatric comorbidity. J Clin Psychiatry. 1994;55:5-11. (Pubitemid 24051910)
2. McElroy SL, Keck PE Jr, Pope HG Jr, et al. Compulsive buying: a report of 20 cases. J Clin Psychiatry. 1994;55:242-248. (Pubitemid 24235836)
3. Black DW, Repertinger S, Gaffney GR, et al. Family history and psychiatric comorbidity in persons with compulsive buying: preliminary findings. Am J Psychiatry. 1998;155:960-963. (Pubitemid 28307610)
4. Koran LM, Faber RJ, Aboujaoude E, et al. Estimated prevalence of compulsive buying behavior in the United States. Am J Psychiatry. 2006;63:1806-1812. (Pubitemid 44522491)
5. Odlaug BL, Grant JE. Impulse-control disorders in a college sample: results from the self-administered Minnesota impulse disorders interview (MIDI). Prim Care Comp J Clin Psychiatry. 2010;12:e1-e5.
6. Grant JE, Levine L, Kim D, et al. Impulse control disorders in adult psychiatric inpatients. Am J Psychiatry. 2005;162:2184-2188. (Pubitemid 41598279)
7. Mueller A, Mueller U, Silbermann A, et al. A randomized, controlled trial of group cognitive-behavioral therapy for compulsive buying disorder: posttreatment and 6-month follow-up results. J Clin Psychiatry. 2008;69:1131-1138. (Pubitemid 352031597)
8. Mitchell JE, Burgard M, Faber R, et al. Cognitive behavioral therapy for compulsive buying disorder. Behav Res Ther. 2006;44:1859-1865. (Pubitemid 44540357)
9. Donahue CB, Odlaug BL, Grant JE. Compulsive buying treated with motivational interviewing and imaginal desensitization [letter]. Ann Clin Psychiatry. 2011;23:226-227.
10. Black DW, Gabel J, Hansen J, et al. A double-blind comparison of fluvoxamine versus placebo in the treatment of compulsive buying disorder. Ann Clin Psychiatry. 2000;12:205-211. (Pubitemid 32046314)
11. Koran LM, Aboujaoude EN, Solvason B, et al. Escitalopram for compulsive buying disorder: a double-blind discontinuation study. J Clin Psychopharmacol. 2007;27:225-227. (Pubitemid 46594952)
12. Koran LM, Bullock KD, Hartston HJ, et al. Citalopram treatment of compulsive shopping: an open-label study. J Clin Psychiatry. 2002;63:704-708.
13. Krystal JH, Petrakis IL, Krupitsky E, et al. NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy. Ann NY Acad Sci. 2003;1003:176-184. (Pubitemid 38083055)
14. Meisner F, Scheller C, Kneitz S, et al. Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine. Neuropsychopharmacol. 2008;33:2228-2236. (Pubitemid 351992085)
15. Ma S, Xu S, Liu B, et al. Long-term treatment of l-3-n-butylphthalide attenuated neurodegenerative changes in aged rats. Naunyn Schmiedebergs Arch Pharmacol. 2009;379:565-574.
16. Van Wageningen H, Jorgensen HA, Specht K, et al. A 1H-MR spectroscopy study of changes in glutamate and glutamine (Glx) concentrations in frontal spectra after administration of memantine. Cereb Cortex. 2010;20:798-803.
17. Grant JE, Chamberlain SR, Odlaug BL, et al. Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study. Psychopharmacol. 2010;212:603-612.
18. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV-Patient Edition (SCID-I/P, Version 2.0). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1995.
19. Monehan PW, Black DW, Gabel J. Reliability and validity of a scale to measure change in a persons compulsive buying. Psychiatry Res. 1996;64:59-67. (Pubitemid 26298083)
20. Kim SW, Grant JE, Potenza MN, et al. The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study. Psychiatry Res. 2009;166:76-84.
21. Guy W. ECDEU Assessment Manual for Psychopharmacology: US Dept Health, Education and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health: 1976:218-222.
22. Sheehan DV. The anxiety disease. New York, NY: Scribner's; 1983.
23. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50-55.
24. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
25. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385-396.
26. Frisch MB, Cornell J, Villaneuva M. Clinical validation of the Quality of Life Inventory: a measure of life satisfaction for use in treatment planning and outcome assessment. Psychol Assess. 1992;41:92-101.
27. Cambridge Cognition Limited. CANTABeclipse, version 3. Cambridge, United Kingdom: Cambridge Cognition Limited; 2006.
28. Lezak MD, Howieson DB, Loring DW, et al. Neuropsychological assessment. New York, NY: Oxford University Press; 2004.
29. Logan GD, Cowan WB, Davis KA. On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol Hum Percept Perform. 1984;10:276-291.
30. Aron AR, Robbins TW, Poldrack RA. Inhibition and the right inferior frontal cortex. Trends Cogn Sci. 2004;8:170-177. (Pubitemid 38429927)
31. Aron AR, Fletcher PC, Bullmore ET, et al. Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci. 2003;6:115-116. (Pubitemid 36182778)
32. Ninan PT, McElroy SL, Kane CP, et al. Placebo-controlled study of fluvoxamine in the treatment of patients with compulsive buying. J Clin Psychopharmacol. 2000;20:362-366. (Pubitemid 30318367)
33. Grant JE, Potenza MN. Treatments for pathological gambling and other impulse control disorders In: Nathan PE, Gorman JM, eds. A guide to treatments that work, 3rd ed. New York, NY: Oxford University Press; 2007:561-577.